Top Markets
#1 Black Phoenix Black Phoenix +823.46%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.62%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.43%
#4 Beam Beam +24.43%
#5 Tutorial Tutorial +24.41%
#6 Bless Bless +19.73%
#7 SAFEcoin SAFEcoin +18.55%
#8 Magma Finance Magma Finance +17.14%
#9 MiL.k Alliance MiL.k Alliance +16.48%
#10 THORChain THORChain +16.18%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
ApicHope Pharmaceutical Co., Ltd ApicHope Pharmaceutical Co., Ltd

ApicHope Pharmaceutical Co., Ltd

300723
Rank in Stocks #5760
ApicHope Pharmaceutical Co., Ltd, along with its various subsidiary entities,... ApicHope Pharmaceutical Co., Ltd, along with its various subsidiary entities, operates primarily in the pharmaceutical sector, focusing on the research, development, production, and distribution of medicinal products. The company boasts an extensive portfolio of offerings that address diverse therapeutic needs, including solutions for infectious diseases, pediatric health, cardiovascular conditions, genitourinary disorders, respiratory ailments, liver and digestive problems, and dermatological complaints. Furthermore, they supply a range of anti-inflammatory and pain-relieving medications. This enterprise, established in 2002, maintains its primary operations in Guangzhou, China. It adopted its current name, ApicHope Pharmaceutical Co., Ltd, in December 2021, having previously been known as Yipinhong Pharmaceutical Co.,Ltd.
Share Price
$5.44
Market Cap
$2.46B
Change (1 day)
4.45%
Change (1 year)
-40.03%
Country
CN
Trade ApicHope Pharmaceutical Co., Ltd (300723)

Category

Healthcare
P/E ratio for ApicHope Pharmaceutical Co., Ltd (300723)
P/E ratio as of 2026 TTM: 0
According to ApicHope Pharmaceutical Co., Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for ApicHope Pharmaceutical Co., Ltd from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.